Chronic Lung Allograft Dysfunction MRI Study
Recruiting
Phase 1
Phase 2
Interventional Study
Chronic Lung Allograft Dysfunction Lung MRI (CLAD)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 100 (estimated)
- Sponsor
- Sean Fain · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This studies purpose is to confirm the efficacy and efficiency of using OE-MRI and MRI with hyperpolarized gas techniques and Iodinated contrast CT scan, this will enhance understanding of CLAD pathophysiology. Moreover, this project is foundational to performing additional studies to establish if novel MRI imaging can serve as an objective confirmatory diagnostic tool for CLAD in post-transplant …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
All subjects-Inclusion Criteria:
* Ages 18-80
* English Speaking Subjects
* Willingness and ability to provide informed consent
* Non-smoker
Lung transplant patients-inclusion criteria:
* \>/= 6 months from lung transplant
* History of bilateral lung transplant
CLAD-free patients-inclusion crite…
Contacts